Investigational hydronidone, when added to entecavir (Baraclude), reduced liver fibrosis for chronic hepatitis B patients, a phase II trial in China found. In an intention-to-treat analysis of 168 ...

Patients with untreated chronic hepatitis B who had metabolic comorbidities were at a higher risk for advanced liver fibrosis and were less likely to see improvement with antiviral therapy than those ...

In an age where advanced diagnostics are widely available, more testing does not always mean better diagnosis. Experts emphasise that the real key lies in choosing the right tests at the right time.

HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases.

Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression of chronic liver diseases such as chronic hepatitis and metabolic ...

Researchers have uncovered a significant mechanism involved in liver fibrosis. Their findings have been published in the journal Gut. The study highlights the extracellular matrix protein 1 (ECM1) as ...

The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is prolonged, whether from alcohol, poor diet, or chronic hepatitis virus ...

Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today ...

Microscopy image showing activated hepatic stellate cells (HSCs), indicated by red staining (left image). Inhibition of CYB1B1 reduces HSC activation (right image), which leads to reduced liver ...

You probably know that foods like oatmeal support heart health and blueberries support brain function, but have you ever ...